| Particulars |
|
|
|
| Company Name
| Natco Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
35.82 |
B.V. (₹) |
461.80 |
| Sales(₹ Cr.) |
4,094.50 |
NP (₹ Cr.) |
1,778.18 |
| NP Var% |
36.00 |
Div% |
300.00 |
| CPS(₹) |
111.60 |
EPS (₹) |
99.30 |
| Traded Value(₹ Lakhs) |
300.97 |
52 Week High |
1,135.00 |
| 52 Week Low |
752.00 |
Price BSE |
1,092.00 |
| Price NSE |
1,092.00 |
Market Capital (₹ Cr.) |
19,552.53 |
| P/C Ratio |
9.80 |
P/E Ratio |
11.00 |
| Price Vs.BV |
2.36 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
528.80 |
| NP(₹ Cr.) |
106.90 |
NP Var % |
-14.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
4,119.60 |
| OPM |
54.49 |
NP |
1,838.50 |
| NP Var% |
-15.32 |
EPS |
83.75 |
| PE |
13.03 |
|
|